Could single-Dose Zepbound Vials be a game-changer for weight loss?
August 2024- Eli Lilly and Company announced Zepbound ® (tirzepatide) 2.5 mg…
FDA Approves Eli Lilly’s Zepbound™ for Obesity Treatment
INDIANAPOLIS: Eli Lilly and Company's (NYSE: LLY) innovative obesity treatment, Zepbound™ (tirzepatide)…